Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant

Long-term disease-free survival in adults with T-cell acute lymphoblastic leukemia (T-ALL) remains poor, particularly after relapse, with few available salvage options. Preclinical data suggest that inhibition of the antiapoptotic protein BCL-2 (B-cell lymphoma 2) either alone or in combination with...

Full description

Bibliographic Details
Main Authors:	Leena T. Rahmat, Anna Nguyen, Haifaa Abdulhaq, Sonam Prakash, Aaron C. Logan, Gabriel N. Mannis
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Case Reports in Hematology
Online Access:	http://dx.doi.org/10.1155/2018/6092646

Similar Items

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia
by: Elisabetta Zappone, et al.
Published: (2020-10-01)

Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: A case report and review of literature
by: Nosha Farhadfar, et al.
Published: (2021-09-01)

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia
by: Jia Liu, et al.
Published: (2021-08-01)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
by: Maansi Joshi, et al.
Published: (2021-03-01)

Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
by: Chen R, et al.
Published: (2015-02-01)

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
by: Paul J. Hampel, et al.
Published: (2021-03-01)

Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)
by: Heather Klocke, et al.
Published: (2020-01-01)

Extramedullary relapse of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation treated by CAR T-cell therapy: a case report
by: Wang D, et al.
Published: (2018-09-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
by: Abhishek Maiti, et al.
Published: (2021-02-01)

Cardiac Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
by: María Facenda-Lorenzo, et al.
Published: (2016-01-01)

Donor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia
by: Kevin C. Miller, et al.
Published: (2020-12-01)

Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation
by: Mona Mahrous Abdelaty, et al.
Published: (2020-06-01)

First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Claire Horgan, et al.
Published: (2020-01-01)

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
by: Ashley McEwan, et al.
Published: (2020-06-01)

Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
by: C. Roolf, et al.
Published: (2018-05-01)

Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
by: Ahmad I. Antar, et al.
Published: (2020-11-01)

Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant
by: Masumi Ueda, et al.

VENETOCLAX FOR RELAPSED ACUTE MYELOID LEUCEMIA AS A “BRIDGE FOR ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANT”: A CASE REPORT
by: A.P. Udo, et al.
Published: (2020-11-01)

Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting
by: Tong J, et al.
Published: (2021-07-01)

Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review
by: Salimah Valliani, et al.
Published: (2020-01-01)

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia
by: Karl Haslam, et al.
Published: (2012-01-01)

Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse‐free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia
by: Jeremy Chang, et al.
Published: (2019-06-01)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
by: Atae Utsunomiya
Published: (2019-10-01)

Targeting T-bet for Prevention of Graft-Versus-Host Disease and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
by: Fu, Jianing
Published: (2015)

Second allogeneic hematopoietic stem cell transplantation in treatment of relapsed acute myeloid leukemia: clinical report of 5 cases
by: LIN Shijia, et al.
Published: (2019-12-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
by: Ipek Yonal-Hindilerden, et al.
Published: (2016-12-01)

Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
by: E. V. Semenova, et al.
Published: (2014-07-01)

Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Lu Wang, et al.
Published: (2017-01-01)

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia
by: Mattia Algeri, et al.
Published: (2021-08-01)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2015-10-01)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2012-10-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Hematopoietic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia
by: Ibrahim Bayram
Published: (2014-02-01)

Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients
by: Riad El Fakih, et al.
Published: (2017-12-01)

Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia
by: Huber H, et al.
Published: (2017-02-01)

The Role of AKT Signaling in T-Cell Acute Lymphoblastic Leukemia Relapse
by: Wilder, Jayme
Published: (2015)

Feasible outcome of blinatumomab followed by allogeneic hematopoietic cell transplantation for adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia in first salvage
by: Jae‐Ho Yoon, et al.
Published: (2019-12-01)

Outcome of allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission: a single institution study
by: Eun-Jung Lee, et al.
Published: (2012-03-01)

Cannot write session to /tmp/vufind_sessions/sess_nfrveh1g0bebk9i5h9a731of6e